AEGiS-SAPA: Obasanjo hails all-Nigerian Aids drug South African Press AssociationImportant note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Obasanjo hails all-Nigerian Aids drug

South African Press Association - August 15, 2005


Nigerian President Olusegun Obasanjo has lauded the production of the first anti-retroviral drugs used to battle Aids to be produced by an indigenous firm in the country, his office said on Monday.

Obasanjo said at the weekend during the presentation of the Aids drug Virex by local drug firm Fidson Healthcare that he is encouraged by the achievement of the company.

He said the firm's feat has proved that "where there is a will, there is a way" to fight the deadly disease, afflicting about 5% of the 130-million-strong Nigerian population.

The president also challenged the company to achieve a similar breakthrough in production of a vaccine for malaria, another killer disease in the country.

Fidson boss Fidelis Ayebae said the drug is produced in both tablets and liquid forms for adults and children, and is 100% formulated and manufactured by Nigerian experts.

He said the new drug, which does not cure Aids but keeps the virus in check, is both affordable and available to affected Nigerians.


050815
SA050802


Copyright © 2005 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .